Home » Topics » BioWorld Science

BioWorld Science
RSS

Paratek Pharmaceuticals submits omadacycline NDAs in U.S.

Feb. 6, 2018

Oricula Therapeutics cleared to begin clinical testing of ORC-13661 in U.S.

Feb. 6, 2018

TBX15 identified as predictor of poor survival in HCC patients

Feb. 6, 2018

FDA expands indication for AMAG's Feraheme

Feb. 6, 2018

Acticor Biotech's phase I study of ACT-017 meets endpoints

Feb. 6, 2018

SapVax announces its most recent achievements

Feb. 6, 2018

Phase III ADVANCE study of Rolontis meets primary endpoint

Feb. 6, 2018

Topline results from phase IIb study of EGP-437

Feb. 6, 2018

IRLAB provides update on its lead development programs, IRL-752 and IRL-790

Feb. 6, 2018

Ozempic and Fiasp launched in the U.S.

Feb. 6, 2018